EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (Under Process) , 

 ISSN 2394-3211

Impact Factor: 4.897

 ICV - 79.57

Abstract

METHICILLIN-RESISTANT STAPHYLOCOCCUS aureus (MRSA) AS A CAUSE OF NOSOCOMIAL INFECTION IN IBADAN, NIGERIA

I. C. Oladipo*, S. B. Ogunsona and M. A. Abayomi

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) is considered to be one of the most important causative agents of nosocomial infections. MRSA is multidrug resistant and immense clinical problem, all things considered, penicillins and other groups of antibiotics routinely utilized against S. aureus has turned out to be useless as treatments. MRSA infections are treated with glycopeptide (vancomycin and teicoplanin) which can prompt new resistance to these drugs. Clinicians and researchers need to understand the organism, the patients and the trends in the antibiotic-resistance patterns, so as to have sufficient data for treatment of methicillin resistant S. aureus infections in hospital. A total of one hundred and twenty (120) samples (from nasal swab, inanimate Objects; such as beds, linens, clinical samples such as wound, urine, blood) were examined. A total of eighty six (86) isolates were confirmed to be S. aureus from the three categories of samples. Methicillin resistant S. aureus (MRSA) was differentiated from methicillin sensitive S. aureus (MSSA) by carrying out antibiotic susceptibility pattern using disk diffusion method with different antibiotics (methicillin, oxacillin, cefoxitin, erythromycin, clindamycin and vancomycin). The prevalence of methicillin resistance among S. aureus isolates was 48.8%. Resistance to cefoxitin was the highest (55.8%) followed by; oxacilllin (53.5%), methicillin (48.8%), erythromycin (34.9%), clindamycin (23.3%) and vancomycin (2.3%). Two vancomycin resistant isolates were obtained among clinical samples (blood and urine). The gathered information affirms that a consistent and dynamic observation of this kind of nosocomial infection is important. The outcomes are valuable for correlation of recurrence of MRSA contamination in other medical clinics. Thorough training, great participation and backing from the hospital board are critical for the fruitful utilization of control measures.

Keywords: .


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2019 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR APRIL ISSUE PUBLISHED

    APRIL 2019 Issue has been successfully launched on 1 April 2019

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 4.161 to 4.897 due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (Under Process)